Moderate Risk of HMPV in Nigeria, Says NCDC Director General
The Director General of the Nigeria Centre for Disease Control and Prevention (NCDC), Dr. Jide Idris, reassured the public on Thursday that Nigeria is not facing a serious threat from the Human Metapneumovirus (HMPV).
Speaking on Channels Television’s program Sunrise Daily, he explained that while HMPV is not a new virus, it is relatively under-recognized. The virus has been linked to respiratory infections over the years, especially in children, the elderly, and individuals with weakened immune systems. Dr. Idris compared it to other respiratory illnesses like the flu, stating that it is one of the common causes of respiratory issues.
HMPV can range from mild cold-like symptoms to more severe respiratory infections, such as bronchitis or pneumonia, particularly among vulnerable populations. These symptoms may include cough, fever, nasal congestion, shortness of breath, and wheezing. The virus spreads through respiratory droplets from coughing and sneezing, as well as close contact and contaminated surfaces. Environments with overcrowding or poor ventilation, like correctional centers or poorly managed camps, increase the risk of transmission.
Currently, there is no specific antiviral treatment or vaccine for HMPV, and recovery relies on supportive care, including rest, hydration, and fever management. The NCDC is actively monitoring the virus and taking guidance from the World Health Organization, maintaining an alert phase for the virus’s potential impact in Nigeria. The organization has also worked with the Federal Ministry of Health and other partners to assess the situation.
Earlier this week, the NCDC issued a public advisory, confirming that a risk assessment of HMPV classified its threat level in Nigeria as moderate. Dr. Idris assured Nigerians that the NCDC is closely monitoring developments and has taken necessary steps to safeguard public health, emphasizing the importance of awareness and preparedness in managing the virus’s spread.
